GoodRx price target raised to $5 from $3.50 at Leerink
Bullish setup on GoodRx due to upside target.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish setup on GoodRx due to upside target.
What happened, with direct paths to the underlying reporting
Leerink Partners raises GDRX target to $5; posted price about $3.73. The higher target indicates a bullish view despite near-term price action.
Target: $5
Posted price: $3.73
Analyst firm: Leerink Partners
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.